FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Russell Lewis

Research Profile

Chemicals & Drugs

Procedures

Disorders

Living Beings

Physiology

Fungal Drug Resistance

Co-author Network

Publications

TOP 3
G N Pongas; Russell Lewis; George Samonis; Dimitrios P Kontoyiannis
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
Rachel N Webb; Julius M Cruse; Russell Lewis
Decreased TLR4 gene expression in leukemic leukocyte populations.
Guillermo Garcia-Effron; Dimitrios P Kontoyiannis; Russell Lewis; David Perlin
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Russell Lewis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: G N Pongas; Russell Lewis; George Samonis; Dimitrios P Kontoyiannis
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15 Suppl 5():93-7.
2009: Rachel N Webb; Julius M Cruse; Russell Lewis
Decreased TLR4 gene expression in leukemic leukocyte populations.
Experimental and molecular pathology 2009;87(2):117-26.
2008: Guillermo Garcia-Effron; Dimitrios P Kontoyiannis; Russell Lewis; David Perlin
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Antimicrobial agents and chemotherapy 2008;52(11):4181-3.
2008: Russell Lewis; Nathaniel D Albert; Dimitrios P Kontoyiannis
Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2008;52(11):4178-80.
2008: G A Lamaris; R Ben-Ami; Russell Lewis; Dimitrios P Kontoyiannis
Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.
The Journal of antimicrobial chemotherapy 2008;62(3):539-42.
2008: Georgios Chamilos; Russell Lewis; Dimitrios P Kontoyiannis
Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(4):503-9.
2008: R Ben-Ami; Russell Lewis; Dimitrios P Kontoyiannis
Immunocompromised hosts: immunopharmacology of modern antifungals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(2):226-35.
2008: Gregory A Lamaris; Russell Lewis; Georgios Chamilos; Gregory S May; Amar Safdar; THOMAS WALSH; Issam I Raad; Dimitrios P Kontoyiannis
Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.
The Journal of infectious diseases 2008;198(2):186-92.
2008: Georgios Chamilos; Russell Lewis; Jianhua Hu; Lianchun Xiao; Tomasz Zal; Michel Gilliet; Georg Halder; Dimitrios P Kontoyiannis
Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(27):9367-72.
2008: Russell Lewis; Nathaniel D Albert; Dimitrios P Kontoyiannis
Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis.
The Journal of antimicrobial chemotherapy 2008;61(5):1140-4.
2008: G A Lamaris; Bita Esmaeli; Georgios Chamilos; A Desai; Roy F Chemaly; Issam I Raad; Amar Safdar; Russell Lewis; Dimitrios P Kontoyiannis
Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(5):343-7.
2008: Georgios Chamilos; Russell Lewis; Gregory A Lamaris; Nathaniel D Albert; Dimitrios P Kontoyiannis
Genomewide screening for genes associated with gliotoxin resistance and sensitivity in Saccharomyces cerevisiae.
Antimicrobial agents and chemotherapy 2008;52(4):1325-9.
2008: Dimitrios P Kontoyiannis; Russell Lewis; Barbara D Alexander; Olivier Lortholary; Françoise Dromer; Krishan L Gupta; George T John; Ramon del Busto; Goran B Klintmalm; Jyoti Somani; G Marshall Lyon; Kenneth Pursell; Valentina Stosor; Patricia Munoz; Ajit P Limaye; Andre C Kalil; Timothy L Pruett; Julia Garcia-Diaz; Atul Humar; Sally Houston; Andrew A House; Dannah Wilde Wray; Susan L Orloff; Lorraine A Dowdy; Robert A Fisher; Joseph Heitman; Nathaniel D Albert; Marilyn M Wagener; Nina Singh
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis.
Antimicrobial agents and chemotherapy 2008;52(2):735-8.
2008: Georgios Chamilos; Russell Lewis; G Lamaris; THOMAS WALSH; Dimitrios P Kontoyiannis
Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage.
Antimicrobial agents and chemotherapy 2008;52(2):722-4.
2008: Russell Lewis
What is the "therapeutic range" for voriconazole?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(2):212-4.
2007: Gregory A Lamaris; Georgios Chamilos; Russell Lewis; Dimitrios P Kontoyiannis
Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster.
The Journal of infectious diseases 2007;196(12):1860-4.
2007: Lillian S Chou; Russell Lewis; Cindy Ippoliti; Richard E Champlin; Dimitrios P Kontoyiannis
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Pharmacotherapy 2007;27(12):1644-50.
2007: Victor Mulanovich; Russell Lewis; Issam I Raad; Dimitrios P Kontoyiannis
Random plasma concentrations of voriconazole decline over time.
The Journal of infection 2007;55(5):e129-30.
2007: Russell Lewis
Pharmacodynamic implications for use of antifungal agents.
Current opinion in pharmacology 2007;7(5):491-7.
2007: Dimitrios P Kontoyiannis; Georgios Chamilos; Russell Lewis; Sergio Giralt; Jorge Cortes; Issam I Raad; John T Manning; Xin Han
Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation.
Cancer 2007;110(6):1303-6.
2007: Georgios Chamilos; Mario Luna; Russell Lewis; Roy F Chemaly; Issam I Raad; Dimitrios P Kontoyiannis
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
Clinical therapeutics 2007;29(9):1980-6.
2007: Georgios Chamilos; Russell Lewis; Nathaniel D Albert; Dimitrios P Kontoyiannis
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences.
Antimicrobial agents and chemotherapy 2007;51(6):2257-9.
2007: Russell Lewis; Guangling Liao; Jinggou Hou; Georgios Chamilos; Randall A Prince; Dimitrios P Kontoyiannis
Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2007;51(4):1253-8.
2007: Russell Lewis; Georgios Chamilos; Randall A Prince; Dimitrios P Kontoyiannis
Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice.
Antimicrobial agents and chemotherapy 2007;51(3):1078-81.
2007: Dimitrios P Kontoyiannis; Georgios Chamilos; Saad A Hassan; Russell Lewis; Nathaniel D Albert; Jeffrey J Tarrand
Increased culture recovery of Zygomycetes under physiologic temperature conditions.
American journal of clinical pathology 2007;127(2):208-12.
2007: Georgios Chamilos; Russell Lewis; Dimitrios P Kontoyiannis
Multidrug-resistant endosymbiotic bacteria account for the emergence of zygomycosis: A hypothesis.
Fungal genetics and biology : FG & B 2007;44(2):88-92.
2007: Georgios Chamilos; Michail S Lionakis; Russell Lewis; Dimitrios P Kontoyiannis
Role of mini-host models in the study of medically important fungi.
The Lancet infectious diseases 2007;7(1):42-55.
2006: Gregory A Lamaris; Georgios Chamilos; Russell Lewis; Amar Safdar; Issam I Raad; Dimitrios P Kontoyiannis
Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(12):1580-4.
2006: Dimitrios P Kontoyiannis; Russell Lewis
Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management.
Infectious disease clinics of North America 2006;20(3):581-607, vi.
2006: Georgios Chamilos; Mario Luna; Russell Lewis; Gerald P Bodey; Roy F Chemaly; Jeffrey J Tarrand; Amar Safdar; Issam I Raad; Dimitrios P Kontoyiannis
Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003).
Haematologica 2006;91(7):986-9.
2006: Russell Lewis
Decision making in antifungal monotherapy versus combination therapy.
Pharmacotherapy 2006;26(6 Pt 2):61S-67S.
2006: Kevin W Garey; Melinda M Neuhauser; David T Bearden; Joan P Cannon; Russell Lewis; Layne O Gentry; Dimitrios P Kontoyiannis
Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
Mycoses 2006;49(3):226-31.
2006: Georgios Chamilos; Michail S Lionakis; Russell Lewis; José L López-Ribot; Stephen P Saville; Nathaniel D Albert; Georg Halder; Dimitrios P Kontoyiannis
Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
The Journal of infectious diseases 2006;193(7):1014-22.
2006: Nina Singh; Ajit P Limaye; Graeme Forrest; Nasia Safdar; Patricia Muñoz; Kenneth Pursell; Sally Houston; Fernando Rosso; Jose G Montoya; Pamela Patton; Ramon del Busto; Jose M Aguado; Robert A Fisher; Goran B Klintmalm; Rachel Miller; Marilyn M Wagener; Russell Lewis; Dimitrios P Kontoyiannis; Shahid Husain
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Transplantation 2006;81(3):320-6.
2006: Georgios Chamilos; Russell Lewis; Dimitrios P Kontoyiannis
Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin.
Antimicrobial agents and chemotherapy 2006;50(2):744-7.
2006: Nathan Wiederhold; Vincent H Tam; Jingduan Chi; Randall A Prince; Dimitrios P Kontoyiannis; Russell Lewis
Pharmacodynamic activity of amphotericin B deoxycholate is associated with peak plasma concentrations in a neutropenic murine model of invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2006;50(2):469-73.
2006: Russell Lewis; Nathan Wiederhold; Randall A Prince; Dimitrios P Kontoyiannis
In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin.
The Journal of antimicrobial chemotherapy 2006;57(2):288-93.
2006: Michail S Lionakis; Georgios Chamilos; Russell Lewis; Nathan Wiederhold; Issam I Raad; George Samonis; Dimitrios P Kontoyiannis
Pentamidine is active in a neutropenic murine model of acute invasive pulmonary fusariosis.
Antimicrobial agents and chemotherapy 2006;50(1):294-7.
2006: Georgios Chamilos; Russell Lewis; Dimitrios P Kontoyiannis
Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole.
Antimicrobial agents and chemotherapy 2006;50(1):96-103.
2005: Russell Lewis; Nathan Wiederhold; Michail S Lionakis; Randall A Prince; Dimitrios P Kontoyiannis
Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center.
Journal of clinical microbiology 2005;43(12):6120-2.
2005: Nathan Wiederhold; Dimitrios P Kontoyiannis; Randall A Prince; Russell Lewis
Attenuation of the activity of caspofungin at high concentrations against candida albicans: possible role of cell wall integrity and calcineurin pathways.
Antimicrobial agents and chemotherapy 2005;49(12):5146-8.
2005: Michail S Lionakis; Johanna Lahdenranta; Jessica Sun; Wei Liu; Russell Lewis; Nathaniel D Albert; Renata Pasqualini; Wadih Arap; Dimitrios P Kontoyiannis
Development of a ligand-directed approach to study the pathogenesis of invasive aspergillosis.
Infection and immunity 2005;73(11):7747-58.
2005: Russell Lewis; Dimitrios P Kontoyiannis
Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro.
The Journal of antimicrobial chemotherapy 2005;56(5):887-92.
2005: Michail S Lionakis; Russell Lewis; Georgios Chamilos; Dimitrios P Kontoyiannis
Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.
Pharmacotherapy 2005;25(9):1174-80.
2005: Vincent H Tam; Amy N Schilling; Giao Vo; Samer Kabbara; Andrea L H Kwa; Nathan Wiederhold; Russell Lewis
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 2005;49(9):3624-30.
2005: Georgios Chamilos; Edith M Marom; Russell Lewis; Michail S Lionakis; Dimitrios P Kontoyiannis
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(1):60-6.
2005: Michail S Lionakis; Russell Lewis; Harrys A Torres; Nathaniel D Albert; Issam I Raad; Dimitrios P Kontoyiannis
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
Diagnostic microbiology and infectious disease 2005;52(1):15-20.
2005: Nathan Wiederhold; Elizabeth A Coyle; Issam I Raad; Randall A Prince; Russell Lewis
Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
The Journal of antimicrobial chemotherapy 2005;55(5):792-5.
2005: Dimitrios P Kontoyiannis; Michail S Lionakis; Russell Lewis; Georgios Chamilos; Mimi Healy; Cheryl Perego; Amar Safdar; Andrew Lamb; Richard Champlin; THOMAS WALSH; Issam I Raad
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
The Journal of infectious diseases 2005;191(8):1350-60.
2005: Michail S Lionakis; Russell Lewis; Gregory S May; Nathan Wiederhold; Nathaniel D Albert; Georg Halder; Dimitrios P Kontoyiannis
Toll-deficient Drosophila flies as a fast, high-throughput model for the study of antifungal drug efficacy against invasive aspergillosis and Aspergillus virulence.
The Journal of infectious diseases 2005;191(7):1188-95.
2005: Russell Lewis; Nathan Wiederhold; Michael E Klepser
In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
Antimicrobial agents and chemotherapy 2005;49(3):945-51.
2005: Dimitrios P Kontoyiannis; Russell Lewis
Caspofungin versus liposomal amphotericin B for empirical therapy.
The New England journal of medicine 2005;352(4):410-4; author reply 410-4.
2005: Russell Lewis; Nathan Wiederhold
Murine model of invasive aspergillosis.
Methods in molecular medicine 2005;118():129-42.
2005: Russell Lewis; Nathan Wiederhold; Jingduan Chi; Xiang Y Han; Krishna Komanduri; Dimitrios P Kontoyiannis; Randall A Prince
Detection of gliotoxin in experimental and human aspergillosis.
Infection and immunity 2005;73(1):635-7.
2004: Vincent H Tam; Amy N Schilling; Russell Lewis; David A Melnick; Adam N Boucher
Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents.
Antimicrobial agents and chemotherapy 2004;48(11):4315-21.
2004: Nathan Wiederhold; Dimitrios P Kontoyiannis; Jingduan Chi; Randall A Prince; Vincent H Tam; Russell Lewis
Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity.
The Journal of infectious diseases 2004;190(8):1464-71.
2004: Russell Lewis; Dimitrios P Kontoyiannis; Dimitrios P Kantoyiannis
Challenges in designing animal studies to detect antagonism of polyene activity.
Antimicrobial agents and chemotherapy 2004;48(8):3211; author reply 3211-2.
2004: Katherine S Barker; Sarah Crisp; Nathan Wiederhold; Russell Lewis; Bart Bareither; James Eckstein; Robert Barbuch; Martin Bard; P David Rogers
Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans.
The Journal of antimicrobial chemotherapy 2004;54(2):376-85.
2004: Dimitrios P Kontoyiannis; Russell Lewis
Toward more effective antifungal therapy: the prospects of combination therapy.
British journal of haematology 2004;126(2):165-75.
2004: Wei Liu; Gregory S May; Michail S Lionakis; Russell Lewis; Dimitrios P Kontoyiannis
Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatus.
Antimicrobial agents and chemotherapy 2004;48(7):2490-6.
2003: Nathan Wiederhold; Russell Lewis; Dimitrios P Kontoyiannis
Invasive aspergillosis in patients with hematologic malignancies.
Pharmacotherapy 2003;23(12):1592-610.
2003: Wei Liu; Michail S Lionakis; Russell Lewis; Nathan Wiederhold; Gregory S May; Dimitrios P Kontoyiannis
Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
Antimicrobial agents and chemotherapy 2003;47(11):3592-7.
2003: Dimitrios P Kontoyiannis; Russell Lewis
Combination chemotherapy for invasive fungal infections: what laboratory and clinical studies tell us so far.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2003;6(5):257-69.
2003: Dimitrios P Kontoyiannis; Russell Lewis; Michail S Lionakis; Nathaniel D Albert; Gregory S May; Issam I Raad
Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.
Diagnostic microbiology and infectious disease 2003;47(2):415-9.
2003: Michail S Lionakis; Russell Lewis; George Samonis; Dimitrios P Kontoyiannis
Pentamidine is active in vitro against Fusarium species.
Antimicrobial agents and chemotherapy 2003;47(10):3252-9.
2003: Russell Lewis; Nathan Wiederhold
The solubility ceiling: a rationale for continuous infusion amphotericin B therapy?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(6):871-2.
2003: Anastasia Antoniadou; Harrys A Torres; Russell Lewis; John Thornby; Gerald P Bodey; Jeffrey P Tarrand; Xiang-Yang Han; Kenneth V I Rolston; Amar Safdar; Issam I Raad; Dimitrios P Kontoyiannis
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
Medicine 2003;82(5):309-21.
2003: Nathan Wiederhold; Russell Lewis
The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy.
Expert opinion on investigational drugs 2003;12(8):1313-33.
2003: Dimitrios P Kontoyiannis; Ray Hachem; Russell Lewis; Gustavo A Rivero; Harrys A Torres; John Thornby; Richard Champlin; Andrew Lamb; Gerald P Bodey; Issam I Raad
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies.
Cancer 2003;98(2):292-9.
2003: Harrys A Torres; Gustavo A Rivero; Russell Lewis; Ray Hachem; Issam I Raad; Dimitrios P Kontoyiannis
Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus.
Diagnostic microbiology and infectious disease 2003;46(1):25-8.
2003: Dimitrios P Kontoyiannis; Russell Lewis; Nir Osherov; Nathaniel D Albert; Gregory S May
Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.
The Journal of antimicrobial chemotherapy 2003;51(2):313-6.
2003: P David Rogers; Robert E Kramer; Janice K Crews; Russell Lewis
The activity of amphotericin B against Candida albicans is not directly associated with extracellular calcium concentration.
The Journal of antimicrobial chemotherapy 2003;51(2):305-12.
2002: D P Kontoyiannis; Russell Lewis; Gregory S May; Nir Osherov; M G Rinaldi
Aspergillus nidulans is frequently resistant to amphotericin B.
Mycoses 2002;45(9-10):406-7.
2002: Russell Lewis; Dimitrios P Kontoyiannis; Rabih O Darouiche; Issam I Raad; Randall A Prince
Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
Antimicrobial agents and chemotherapy 2002;46(11):3499-505.
2002: Russell Lewis; Randall A Prince; Jingduan Chi; Dimitrios P Kontoyiannis
Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2002;46(10):3208-14.
2002: Russell Lewis
Pharmacotherapy of Candida bloodstream infections: new treatment options, new era.
Expert opinion on pharmacotherapy 2002;3(8):1039-57.
2002: Ellen E Roling; Michael E Klepser; Ashley Wasson; Russell Lewis; Erika J Ernst; Michael A Pfaller
Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods.
Diagnostic microbiology and infectious disease 2002;43(1):13-7.
2002: Russell Lewis; Hsiu-Jung Lo; Issam I Raad; Dimitrios P Kontoyiannis
Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth.
Antimicrobial agents and chemotherapy 2002;46(4):1153-5.
2002: Dimitrios P Kontoyiannis; Russell Lewis
Antifungal drug resistance of pathogenic fungi.
Lancet 2002;359(9312):1135-44.
2002: Russell Lewis; D J Diekema; S A Messer; Michael A Pfaller; Michael E Klepser
Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species.
The Journal of antimicrobial chemotherapy 2002;49(2):345-51.
2002: Dimitrios P Kontoyiannis; Bhavananda T Reddy; Harrys A Torres; Mario Luna; Russell Lewis; Jeffrey J Tarrand; Gerald P Bodey; Issam I Raad
Pulmonary candidiasis in patients with cancer: an autopsy study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(3):400-3.
2001: P Pietrucha-Dilanchian; Russell Lewis; H Ahmad; A E Lechin
Candida lusitaniae catheter-related sepsis.
The Annals of pharmacotherapy 2001;35(12):1570-4.
2001: D J Keele; V C DeLallo; Russell Lewis; Erika J Ernst; Michael E Klepser
Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
Diagnostic microbiology and infectious disease 2001;41(3):121-6.
2001: Russell Lewis; Dimitrios P Kontoyiannis
Rationale for combination antifungal therapy.
Pharmacotherapy 2001;21(8 Pt 2):149S-164S.
2001: Dimitrios P Kontoyiannis; Borje S Andersson; Russell Lewis; Issam I Raad
Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(5):E94-6.
2000: Dimitrios P Kontoyiannis; Russell Lewis; N Sagar; G May; Randall A Prince; Kenneth V I Rolston
Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy.
Antimicrobial agents and chemotherapy 2000;44(10):2915-8.
2000: Michael E Klepser; D Malone; Russell Lewis; Erika J Ernst; Michael A Pfaller
Evaluation of voriconazole pharmacodynamics using time-kill methodology.
Antimicrobial agents and chemotherapy 2000;44(7):1917-20.
2000: Russell Lewis; Michael E Klepser; Erika J Ernst; MIchael Snabes; Ronald Jones
Comparison of oral immediate-release (IR) and extended-release (ER) metronidazole bactericidal activity against Bacteroides spp. using an in vitro model of infection.
Diagnostic microbiology and infectious disease 2000;37(1):51-5.
2000: Russell Lewis; Michael E Klepser; Michael A Pfaller
In vitro pharmacodynamic characteristics of flucytosine determined by time-kill methods.
Diagnostic microbiology and infectious disease 2000;36(2):101-5.
1999: Russell Lewis; Michael E Klepser; Erika J Ernst; Brian C Lund; Douglas J Biedenbach; Ronald Jones
Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infection.
Antimicrobial agents and chemotherapy 1999;43(8):2005-9.
1999: Russell Lewis; Michael E Klepser
The changing face of nosocomial candidemia: epidemiology, resistance, and drug therapy.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1999;56(6):525-33; quiz 534-5.
1998: Michael E Klepser; Russell Lewis; Michael A Pfaller
Therapy of Candida infections: susceptibility testing, resistance, and therapeutic options.
The Annals of pharmacotherapy 1998;32(12):1353-61.
1998: Russell Lewis; Brian C Lund; Michael E Klepser; Erika J Ernst; Michael A Pfaller
Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.
Antimicrobial agents and chemotherapy 1998;42(6):1382-6.
1998: Russell Lewis; Michael E Klepser; Michael A Pfaller
Update on clinical antifungal susceptibility testing for Candida species.
Pharmacotherapy 1998;18(3):509-15.
1998: Michael E Klepser; Erika J Ernst; Russell Lewis; Michael E Ernst; Michael A Pfaller
Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.
Antimicrobial agents and chemotherapy 1998;42(5):1207-12.